42 related articles for article (PubMed ID: 1891986)
21. Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis.
Biegler BW; Yan SX; Ortega SB; Tennakoon DK; Racke MK; Karandikar NJ
J Neuroimmunol; 2011 May; 234(1-2):131-40. PubMed ID: 21397340
[TBL] [Abstract][Full Text] [Related]
22. Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.
Turley DM; Miller SD
Results Probl Cell Differ; 2010; 51():217-35. PubMed ID: 19130025
[TBL] [Abstract][Full Text] [Related]
23. CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Howard LM; Neville KL; Haynes LM; Dal Canto MC; Miller SD
J Virol; 2003 Feb; 77(3):2247-50. PubMed ID: 12525660
[TBL] [Abstract][Full Text] [Related]
24. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
Karandikar NJ; Crawford MP; Yan X; Ratts RB; Brenchley JM; Ambrozak DR; Lovett-Racke AE; Frohman EM; Stastny P; Douek DC; Koup RA; Racke MK
J Clin Invest; 2002 Mar; 109(5):641-9. PubMed ID: 11877472
[TBL] [Abstract][Full Text] [Related]
25. CTLA-4: a negative regulator of autoimmune disease.
Karandikar NJ; Vanderlugt CL; Walunas TL; Miller SD; Bluestone JA
J Exp Med; 1996 Aug; 184(2):783-8. PubMed ID: 8760834
[TBL] [Abstract][Full Text] [Related]
26. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
27. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
28. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
29. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
30. Immunopathogenesis of multiple sclerosis.
Wekerle H
Acta Neurol (Napoli); 1991 Apr; 13(2):197-204. PubMed ID: 1891986
[TBL] [Abstract][Full Text] [Related]
31. [A view for understanding the pathogenesis of multiple sclerosis].
Tabira T
Rinsho Shinkeigaku; 1995 Dec; 35(12):1493-5. PubMed ID: 8752441
[TBL] [Abstract][Full Text] [Related]
32. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Friese MA; Fugger L
Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
